Skip to content

Photoacoustic Imaging of Foot Wound

Photoacoustic Imaging in Wound Evaluation and Treatment Guidance

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07216599
Enrollment
25
Registered
2025-10-14
Start date
2025-10-28
Completion date
2026-12-31
Last updated
2025-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Foot Ulcer

Brief summary

This pilot device trial aims to test the feasibility of using photoacoustic images to monitor tissue perfusion and to guide post-surgical wound treatment. Through this pilot study, the investigators will test the feasibility, identify any practical issues, and acquire essential information (e.g., drop-off rate, variation in wound healing rate) to guide future large-scale studies.

Detailed description

This pilot device trial aims to test the feasibility of using photoacoustic images to monitor tissue perfusion and to guide post-surgical wound treatment. Through this pilot study, the investigators will test the feasibility, identify any practical issues, and acquire essential information (e.g., drop-off rate, variation in wound healing rate) to guide future large scale studies. For recruited patients, wound care will be guided by both photoacoustic imaging and Kent imaging, a multi-spectral imaging technique for tissue oxygenation mapping. None of the techniques is currently used in the clinic as standard care.

Interventions

DEVICEPhotoacoustic imaging and multispectral imaging

Use photoacoustic and Kent imaging devices that can image vasculature and assess tissue perfusion on the foot.

Sponsors

National Institute for Biomedical Imaging and Bioengineering (NIBIB)
CollaboratorNIH
State University of New York at Buffalo
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with a chronic wound on the foot that is presumed to be due to arterial insufficiency.

Exclusion criteria

* Patients with a massive deep tissue infection. * Patients with preexisting skin conditions, such as melanoma, psoriasis, in areas close to the wound(s). * Noncompliant patients who do not adhere to care plans. * Pregnant women. * Adults unable to consent.

Design outcomes

Primary

MeasureTime frameDescription
Treatment fidelity rate12 monthsThe ratio of cases received additional clinical assessment due to photoacoustic imaging results.
Percentile healing score12 monthsThe healing score will be defined as the ratio of the healed wound area versus the pre-treatment wound area (1-(post-treatment wound area)/(pre-treatment wound area)). A percentile healing value of 100% indicates that the wound is fully healed, while a value of 0% indicates that the wound area does not change.

Secondary

MeasureTime frameDescription
Recruitment rate12 monthsThe ratio of recruited patients to the total number of eligible patients

Countries

United States

Contacts

Primary ContactJun Xia, Ph.D.
junxia@buffalo.edu716-645-8628

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026